AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development

NORTH CHICAGO, Ill., Sept. 29, 2026 // -- AbbVie (NYSE:ABBV) is investing in its artificial intelligence (AI) infrastructure through a new partnership with Valkai, a life sciences AI platform designed to help accelerate the pace at which scientific innovation reaches patients.Through its…